戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 h a more complete data set and perform a BMI sensitivity test.
2 performed slightly inferior to baySeq in the sensitivity test.
3 ucose homeostasis evaluated using an insulin sensitivity test.
4           Results are robust to a variety of sensitivity tests.
5 tive vs subjective olfactory assessment) and sensitivity tests.
6  copy number alterations as well as compound-sensitivity tests.
7 ough sequencing depth analysis and parameter sensitivity tests.
8 after excluding potential confounders during sensitivity tests.
9 the molecular marker 'Kelch 13' and in vitro sensitivity tests.
10 hown by anxiety-like, nociception, and touch-sensitivity tests.
11 t can fit all the data and satisfy extensive sensitivity tests.
12 rnerstone of tuberculosis diagnosis and drug sensitivity testing.
13        The 6 metrics remained significant on sensitivity testing.
14                           These persisted on sensitivity testing.
15 ion including VA, color vision, and contrast sensitivity testing.
16 y be useful clinical surrogates for contrast sensitivity testing.
17 d shortening time to result in antimicrobial sensitivity testing.
18 nology perimetry and equivalent noise motion sensitivity testing.
19 icipants were selected randomly for contrast sensitivity testing.
20 itivity test and the Spaeth-Richman Contrast Sensitivity test; (2) a performance based measure: the C
21 alized linear mixed model was coupled with a sensitivity test after controlling for covariates to est
22 ning, routine testing panels, and antibiotic sensitivity testing all lead to different policy options
23                                    Extensive sensitivity tests allow us to quantify the contributions
24                                 The two-step sensitivity test allows for the interpretation, understa
25  coherence tomography, Pelli-Robson Contrast Sensitivity test and the Spaeth-Richman Contrast Sensiti
26 ncluded 327 subjects that underwent contrast sensitivity testing and another 114 subjects for defocus
27 o determine the concordance of antimicrobial sensitivity testing and genome-derived resistance, and n
28  analyses, as well as medium-throughput drug sensitivity testing and genome-wide CRISPR-Cas9 screenin
29   However, power was limited for some of the sensitivity tests and further studies with relevant data
30                                  A series of sensitivity tests and hypothetical models were carried o
31 important for the interpretation of in vitro sensitivity tests and molecular markers for artemisinin
32 tion for an additional 43 outcomes, applying sensitivity tests and power analyses.
33  show sensitivity comparable with other high-sensitivity tests and superior specificity, increasing i
34                                     Contrast sensitivity tests and VF mean deviation were associated
35 ly significant correlations between contrast sensitivity tests and VF mean deviation with VRQoL measu
36 ed, however, in an accompanying prespecified sensitivity test, and further supplementary analyses.
37 ence tomography, color vision testing, light sensitivity testing, and electroretinograms (retinal ima
38 tion, retinal imaging, perimetry, full-field sensitivity testing, and pupillometry.
39 s, routine laboratory panels, and antibiotic sensitivity testing, and that the practices for handling
40 color vision test; automated static contrast sensitivity test; and global electroretinography.
41                                 The contrast sensitivity test appeared to have some advantage in diff
42                                        These sensitivity tests are used to derive crop model emulator
43                                     However, sensitivity tests based on pattern correlation analyses
44 icular drusen (RDR) have focused on photopic sensitivity testing but have not specifically assessed s
45 elation between oxacillin disc and automated sensitivity testing, changing epidemiology and methodolo
46                                        These sensitivity tests confirm that Southern Ocean CREs are s
47                                        Model sensitivity tests confirmed the contribution of the 30-g
48  (WST), processing speed (PST), and contrast sensitivity tests (CST).
49                                Applying high-sensitivity testing (detection limit approximately 1 in
50            Detailed testing with a vibration sensitivity testing device in a subgroup of 47 women sho
51                                 We devised a sensitivity-tested distance measure that enables inter-i
52 ng rifampin resistance using phenotypic drug sensitivity testing (DST) as the reference standard in 3
53 lized chemotherapy selected by in vitro drug sensitivity testing (DST) compared with empiric regimens
54 y relevant time scale some weeks before drug sensitivity testing (DST) data are available, and they a
55 , which combines genomic profiling with drug sensitivity testing (DST) of patient-derived tumor cells
56 echnique, and the extended Fourier Amplitude Sensitivity Test (eFAST).
57 te model spin-up, permit thorough parametric sensitivity tests, enable pool-based data assimilation,
58                                         High sensitivity testing for C-reactive protein (hsCRP) has r
59 ants underwent photopic and mesopic contrast sensitivity testing for targets from 1.5-18 cycles per d
60                                     However, sensitivity tests for case-control studies showed a lack
61 d visual acuity, microperimetry, and retinal sensitivity tests for comparison of baseline values with
62                                              Sensitivity tests for pleiotropic distortion were mostly
63 ied clinically and with chromatic full-field sensitivity testing (FST), optical coherence tomography
64 tions, including regenerative medicine, drug sensitivity testing, gene expression profiling and xenog
65 ther than BCL-2, using combined ex vivo drug sensitivity testing, genetic perturbation, and transcrip
66                                              Sensitivity tests highlighted that the models are sensit
67     Concerns over the reliability of routine sensitivity testing in coagulase-negative staphylococci
68 s in health-care settings in Kenya, and drug sensitivity testing in Moldova.
69 hloride, and streptomycin (and rifabutin, if sensitivity testing included it), and, if RFLP testing w
70                     Estimates were robust to sensitivity tests, including controlling for monthly num
71                                              Sensitivity tests indicate that the EVT results are rela
72                                              Sensitivity tests indicate that the forecast maximum mag
73                                 The two-step sensitivity test is illustrated on a regionalized, nonli
74                                     Contrast sensitivity testing is assuming a prominent place in our
75 of-seeing curves, was lowest at the abnormal sensitivity test location in the subjects with glaucoma
76 ged by approximately 90 msec in the abnormal sensitivity test location of patients with glaucoma comp
77 ty in tests of moderately damaged and normal sensitivity test locations in subjects with glaucoma.
78       Results suggest that photopic contrast sensitivity testing may not help us understand future cr
79                                         Drug sensitivity testing of CTC lines with multiple mutations
80                                              Sensitivity testing of individual factors shows that loc
81                                   Antibiotic sensitivity testing of Salmonella isolates was performed
82 ion of LmCYP51B and LbCYP51B, with fungicide sensitivity testing of the transformants, suggests that
83                           Moreover, auditory sensitivity tests of Ae. aegypti's hearing organ, made f
84                                    Fungicide sensitivity testing on isolates shows that they sometime
85 of high tuberculosis burden should have drug-sensitivity testing on isolates to ensure appropriate tr
86  regimens are designed based on culture drug sensitivity test patterns and previous drug exposures, a
87  regimens are designed based on culture-drug sensitivity test patterns, previous drug-exposures and a
88 ften not detected in the standard antibiotic sensitivity tests performed in clinical laboratories.
89                                              Sensitivity tests performed with the PD models show a cl
90 r tests (BBB, Beam walking, MotoRater) and a sensitivity test (Plantar test).
91                                              Sensitivity tests reinforce this finding.
92 cal treatment prior to receipt of individual sensitivity testing results.
93                                              Sensitivity tests reveal that LRU is more sensitive to p
94                                A devaluation sensitivity test revealed that both groups could inhibit
95                                          The sensitivity test revealed that the proposed sensor has a
96                              Subsequent drug sensitivity testing revealed over 100-fold increase of c
97    Increased use of blood cultures including sensitivity testing, routine surface cultures of the neo
98                                              Sensitivity tests show that uncertainty of Cnu dep was l
99                                          The sensitivity test showed that upon the addition of target
100 ate conditions, reproducing mean yields from sensitivity test simulations with deviations of ca. 2% f
101                                              Sensitivity tests suggest that LGM ELAs could have persi
102                                          The sensitivity tests suggest that the results are robust to
103                                   A range of sensitivity tests suggests that these results are robust
104             From Dam methylation and HindIII sensitivity tests, the methylation loci were predicted t
105 ddition, all patients underwent cough reflex sensitivity testing to citric acid, and 66 patients unde
106  evaluated the utility of ex vivo venetoclax sensitivity testing to predict treatment responses to ve
107 egies and test characteristics, such as test sensitivity, test turnaround time, and testing interval,
108                                              Sensitivity testing using serially diluted DNA conjugate
109 ng early (within hours after a negative high-sensitivity test) viral-load profiles to guide the appro
110 sual processing speed assessed by the Visual Sensitivity Test (VST) in identifying the risk of future
111                     Of the 8,640 patients, a sensitivity test was conducted on 606 patients with AD-a
112                                Antimicrobial sensitivity testing was carried out by the standard prot
113                      Initial specificity and sensitivity testing was performed using stored known T.
114                           In vitro acyclovir sensitivity testing was performed using the dye uptake a
115 per minute (KITT) during intravenous insulin sensitivity tests was identical in the CDP571 and placeb
116 rasite clearance half-life and in vitro drug sensitivity testing were performed using standard method
117                                              Sensitivity tests were conducted to examine the robustne
118 ntraperitoneal glucose tolerance and insulin sensitivity tests were performed to assess glycemic func
119        The combination of sophisticated drug sensitivity testing with advanced in vitro tumor models
120 ision medicine (FPM), combining ex vivo drug sensitivity testing with genomic profiling to identify t
121 s on aromatic SOA formation, but preliminary sensitivity tests with updated SOA yield parameters base
122                                              Sensitivity tests with variation in fault permeability s
123                                              Sensitivity tests yielded consistent findings after we e

 
Page Top